system: You are a contract-analysis assistant performing a span-extraction task. You are given an excerpt from a commercial contract and the name of a clause type to locate within it.

Return the exact text of the requested clause, copied verbatim from the excerpt — identical wording and punctuation, with no paraphrasing, summarising, explanation, or added commentary.

The excerpt is one window of a much longer contract and often will not contain the requested clause. If the requested clause does not appear in this excerpt, respond with exactly: Not found.

Output only the extracted clause text, or the exact string `Not found.` — nothing else.

user: Contract excerpt:
"""
[…***…] intervals. The Reserved Capacity Fee payments shall be […***…] against Roche's Binding Order for such period, the amount of the Reserved Capacity Fee being […***…]. Actual Sample Profiling costs, based on delivery of Sample Results during the […***…] to which the Reserved Capacity Fee applies, shall be […***…]. If actual Sample Profiling exceeds the amount of Sample Profiling paid by the Reserved Capacity Fees, then […***…]. Roche shall pay FMI for […***…]. If a Binding Order causes Roche to […***…]. Fees for Binding Orders shall […***…]. 8.2.1.2 Per Sample Profiling Fees The per Sample Profiling fees (notwithstanding the Reserved Capacity Fee) shall be as follows: […***…]. 8.2.2 Molecular Information Database Access and Database Queries Fees For Molecular Information Database Access and performance of Database Queries by FMI, Roche will pay FMI a total of […***…] of the Database Term, (the "Database Access Fee"), which is comprised of funding for […***…] FTEs, each at the FTE Rate, for performance of such Database Queries and delivery of Database Insights, and a Database Access Fee of […***…]. Roche shall pay to FMI the Database Access Fee […***…] installments of […***…], each payable every […***…] of the Database term and within […***…] after receipt by Roche of an invoice from FMI. 8.3 Immunotherapy Testing Platform Development Budget and Fees 8.3.1 R&D Plan Budget Roche shall be solely responsible for Roche's costs under the Immunotherapy Testing Platform Development Budget. Roche will pay FMI […***…] of FMI Development Cost as agreed in the Immunotherapy Testing Platform Budget for development of the Immuno- Biomarker Discovery Platform. Roche will pay […***…] of FMI Development Cost as agreed in the Immunotherapy Testing Platform Budget for Signature Identification. ***Confidential Treatment Requested*** - 36 - Such reimbursement of FMI Development Cost shall be paid […***…] in arrears. Each […***…], FMI shall invoice Roche for its share of FMI Development Cost incurred in the previous […***…]. Invoices shall be payable within […***…] after receipt by Roche of an invoice from FMI. 8.3.2 Payments for Achieving Certain Immunotherapy Testing Platform Development Events In addition to payment of the Immunotherapy Testing Platform Development Budget as specified above, Roche shall pay FMI: (i) […***…] on Initiation of the first Roche Clinical Study utilizing a Clinical Study assay, […***…]. (ii) […***…] on Initiation of the first Roche Clinical Study utilizing a Clinical Study assay, […***…]. (iii) […***…] on Initiation of the first Roche Clinical Study utilizing a Clinical Study assay, […***…]. 8.3.3 Immuno Clinical Study Assays requested by Roche Roche will pay […***…] of FMI's Development Costs for development of Immuno Clinical Study Assays as may be requested by Roche, subject to an agreed upon budget for such development as provided for in Section 3.2.5. 8.3.4 Immunotherapy CDx Assays If the Parties chose to develop an Immunotherapy CDx Assay, they the Parties shall agree to Roche paying certain costs and milestones for such Immunotherapy CDx assay. 8.4 ctDNA Platform Financial Terms FMI will be responsible for all FMI Development Cost for the ctDNA Platform Development. As part of the agreed upon ctDNA R&D Plan, FMI will provide sample testing performed under such ctDNA R&D Plan at no cost to Roche (other than Roche's cost in supplying FMI the Samples specified in the ctDNA R&D Plan). Roche will pay FMI […***…] if FMI successfully […***…] set forth in the R&D Plan ("Initial Roche ctDNA Assay") within […***…] from [… ***…] (the "First ctDNA Milestone Date"). Payment by Roche shall be made within […***…] after achieving the First ctDNA Milestone Date and the receipt by Roche of an invoice from FMI. In addition, Roche will pay FMI […***…] if FMI successfully […***…] as agreed to in the R&D Plan; provided that […***…] (the "Second ctDNA Milestone Date"). Payment by Roche shall be made within […***…] after achieving the Second ctDNA Milestone Date and the receipt by Roche of an invoice from FMI. The Parties may develop additional ctDNA Assays for use as Clinical Study assays, subject to an agreed financial structure for such work under the R&D Plan. Such additional development work will be conducted, if at all, pursuant to an amendment to this Agreement or a separate written agreement between the Parties. ***Confidential Treatment Requested*** - 37 - 8.5 CDx Development Financial Terms 8.5.1 CDx Development Costs Roche shall pay FMI […***…] of FMI Development Cost for CDx Development of Investigational markers in compliance with the investigational CDx budget that forms part of the R&D Plan. FMI shall pay […***…] of the FMI Development Cost for
"""

Extract the exact clause related to "Liquidated Damages" from the excerpt above.

assistant: Not found.